Irhythm Technologies Share Price Today
(NASDAQ: IRTC)

Name: Irhythm Technologies Share Price Today (NASDAQ: IRTC) - Irhythm Technologies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Irhythm Technologies share price is $108.85 & ₹9,430.76 as on 1 Feb 2025, 2.30 'hrs' IST

$108.85

▲

1.11

(1.03%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Irhythm Technologies share price in Dollar and Rupees. Guide to invest in Irhythm Technologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Irhythm Technologies, along with analyst recommendations, forecasts, and comprehensive financials.

Irhythm Technologies share price movements

Today's Low: $106.89
Today's High: $109.81
$108.85
1.81%
Downside
Day's Volatility :2.66%
Upside
0.87%
52 Weeks Low: $55.92
52 Weeks High: $124.12
$108.85
48.63%
Downside
52 Weeks Volatility :54.95%
Upside
12.3%

Irhythm Technologies (IRTC) Returns

Period	Irhythm Technologies, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	33.66%	-0.6%	0.0%
6 Months	53.81%	-2.8%	0.0%
1 Year	-6.98%	3.3%	0.0%
3 Years	-10.59%	11.6%	-13.7%

Irhythm Technologies (IRTC) Key Statistics

in dollars & INR

Previous Close	$107.74
Open	$108.15
Today's High	$109.805
Today's Low	$106.885
Market Capitalization	$3.4B
Today's Volume	$374.6K
52 Week High	$124.115
52 Week Low	$55.92
Revenue TTM	$560.0M
EBITDA	$-90.6M
Earnings Per Share (EPS)	$-4.85
Profit Margin	-26.9%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-103.34%

How to invest in Irhythm Technologies Stock (IRTC) from India?

It is very easy for Indian residents to invest directly in Irhythm Technologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Irhythm Technologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Irhythm Technologies or IRTC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Irhythm Technologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Irhythm Technologies shares which would translate to 0.008 fractional shares of Irhythm Technologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Irhythm Technologies, in just a few clicks!

Returns in Irhythm Technologies (IRTC) for Indian investors in Rupees

The Irhythm Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Irhythm Technologies investment value today

Current value as on today

₹97,578

Returns

₹2,422

(-2.42%)

Returns from Irhythm Technologies Stock

₹6,982 (-6.98%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Irhythm Technologies (IRTC)

-20%

Period: Jan 2, 2025 to Feb 1, 2025. Change in 30 Days versus previous period

Search interest for Irhythm Technologies Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Irhythm Technologies

Vanguard Group Inc
9.96%
Artisan Partners Limited Partnership
8.88%
BlackRock Inc
8.18%
Sands Capital Management, LLC
6.78%
Capital Research Global Investors
6.25%
Mackenzie Investments
4.54%

Analyst Recommendation on Irhythm Technologies

Buy

88%Buy

11%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Irhythm Technologies(by analysts ranked 0 to 5 stars)

Based on 18 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Irhythm Technologies Stock (IRTC)

What analysts predicted

Upside of 1.67%

Target:

$110.67

Current:

$108.85

Insights on Irhythm Technologies Stock (Ticker Symbol: IRTC)

Price Movement
In the last 1 month, IRTC stock has moved up by 20.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 148.04M → 147.53M (in $), with an average decrease of 0.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -20.10M → -46.18M (in $), with an average decrease of 129.7% per quarter
IRTC vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 57.9% return, outperforming this stock by 69.8%
IRTC vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.3% return, outperforming this stock by 148.9%
Price to Sales
ForIRTC every $1 of sales, investors are willing to pay $6.0, whereas for Boston Scientific Corp., the investors are paying $9.5 for every $1 of sales.

IRTC Irhythm Technologies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$147.3M	↑ 49.52%
Net Income	$-48.3M	↑ 64.11%
Net Profit Margin	-32.78%	↓ 2.91%

	FY19	Y/Y Change
Revenue	$214.6M	↑ 45.66%
Net Income	$-54.6M	↑ 13.02%
Net Profit Margin	-25.43%	↑ 7.35%

	FY20	Y/Y Change
Revenue	$265.2M	↑ 23.59%
Net Income	$-43.8M	↓ 19.68%
Net Profit Margin	-16.53%	↑ 8.9%

	FY21	Y/Y Change
Revenue	$322.8M	↑ 21.74%
Net Income	$-101.4M	↑ 131.26%
Net Profit Margin	-31.4%	↓ 14.87%

	FY22	Y/Y Change
Revenue	$410.9M	↑ 27.29%
Net Income	$-116.2M	↑ 14.6%
Net Profit Margin	-28.27%	↑ 3.13%

	FY23	Y/Y Change
Revenue	$492.7M	↑ 19.9%
Net Income	$-123.4M	↑ 6.24%
Net Profit Margin	-25.05%	↑ 3.22%

	Q2 FY23	Q/Q Change
Revenue	$124.1M	↑ 11.39%
Net Income	$-18.5M	↓ 52.74%
Net Profit Margin	-14.89%	↑ 20.21%

	Q3 FY23	Q/Q Change
Revenue	$124.6M	↑ 0.38%
Net Income	$-27.1M	↑ 46.72%
Net Profit Margin	-21.76%	↓ 6.87%

	Q4 FY23	Q/Q Change
Revenue	$132.5M	↑ 6.35%
Net Income	$-38.7M	↑ 42.72%
Net Profit Margin	-29.2%	↓ 7.44%

	Q1 FY24	Q/Q Change
Revenue	$131.9M	↓ 0.44%
Net Income	$-45.7M	↑ 18.01%
Net Profit Margin	-34.61%	↓ 5.41%

	Q2 FY24	Q/Q Change
Revenue	$148.0M	↑ 12.22%
Net Income	$-20.1M	↓ 55.97%
Net Profit Margin	-13.58%	↑ 21.03%

	Q3 FY24	Q/Q Change
Revenue	$147.5M	↓ 0.34%
Net Income	$-46.2M	↑ 129.68%
Net Profit Margin	-31.3%	↓ 17.72%

	FY18	Y/Y Change
Profit	$108.7M	↑ 53.55%

	FY19	Y/Y Change
Profit	$162.1M	↑ 49.08%

	FY20	Y/Y Change
Profit	$194.9M	↑ 20.25%

	FY21	Y/Y Change
Profit	$213.6M	↑ 9.58%

	FY22	Y/Y Change
Profit	$281.6M	↑ 31.87%

	FY23	Y/Y Change
Profit	$331.8M	↑ 17.82%

	Q2 FY23	Q/Q Change
Profit	$86.2M	↑ 13.93%

	Q3 FY23	Q/Q Change
Profit	$82.5M	↓ 4.35%

	Q4 FY23	Q/Q Change
Profit	$87.4M	↑ 6.0%

	Q1 FY24	Q/Q Change
Profit	$87.5M	↑ 0.1%

	Q2 FY24	Q/Q Change
Profit	$103.5M	↑ 18.23%

	Q3 FY24	Q/Q Change
Profit	$101.5M	↓ 1.93%

	FY18	Y/Y Change
Operating Cash Flow	$-29.1M	↑ 94.94%
Investing Cash Flow	$34.1M	↓ 198.37%
Financing Cash Flow	$6.3M	↓ 3.51%

	FY19	Y/Y Change
Operating Cash Flow	$-21.9M	↓ 24.79%
Investing Cash Flow	$-89.3M	↓ 361.67%
Financing Cash Flow	$111.6M	↑ 1670.2%

	FY20	Y/Y Change
Operating Cash Flow	$-13.8M	↓ 37.07%
Investing Cash Flow	$-132.4M	↑ 48.3%
Financing Cash Flow	$214.3M	↑ 92.08%

	FY21	Y/Y Change
Operating Cash Flow	$-37.8M	↑ 174.39%
Investing Cash Flow	$105.3M	↓ 179.51%
Financing Cash Flow	$-28.6M	↓ 113.33%

	FY22	Y/Y Change
Operating Cash Flow	$-23.0M	↓ 39.05%
Investing Cash Flow	$-52.4M	↓ 149.81%
Financing Cash Flow	$26.7M	↓ 193.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-4.6M	↓ 85.13%
Investing Cash Flow	$9.0M	↑ 135.84%
Financing Cash Flow	$4.4M	↑ 384.09%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.2M	↓ 126.16%
Investing Cash Flow	$-15.4M	↓ 271.36%
Financing Cash Flow	$66.0K	↓ 98.49%

Irhythm Technologies Technicals Summary

Sell

Neutral

Buy

Irhythm Technologies is currently in a neutral trading position according to technical analysis indicators.

Irhythm Technologies (IRTC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Irhythm Technologies, Inc.	21.7%	53.81%	-6.98%	-10.59%	23.16%
Medtronic Plc	13.21%	13.06%	4.69%	-11.11%	-24.31%
Edwards Lifesciences Corp.	-0.19%	19.36%	-15.81%	-35.07%	-3.98%
Boston Scientific Corp.	14.52%	40.3%	58.8%	140.23%	138.71%
Stryker Corporation	9.08%	23.85%	14.11%	56.04%	80.86%
Abbott Laboratories	12.77%	17.77%	14.58%	-1.68%	45.0%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Irhythm Technologies, Inc.	NA	NA	0.0	-3.09	-1.03	-0.09	NA	2.29
Medtronic Plc	28.13	28.13	1.56	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	28.3	28.3	6.72	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	85.16	85.16	1.86	2.46	0.09	0.05	NA	14.05
Stryker Corporation	50.25	50.25	2.73	13.51	0.19	0.07	0.01	52.86
Abbott Laboratories	16.74	16.74	2.32	5.15	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Irhythm Technologies, Inc.	Buy	$3.4B	23.16%	NA	-26.9%
Medtronic Plc	Buy	$118.0B	-24.31%	28.13	12.06%
Edwards Lifesciences Corp.	Buy	$43.2B	-3.98%	28.3	65.86%
Boston Scientific Corp.	Buy	$151.9B	138.71%	85.16	11.26%
Stryker Corporation	Buy	$148.8B	80.86%	50.25	16.34%
Abbott Laboratories	Buy	$221.9B	45.0%	16.74	13.99%

Irhythm Technologies Dividend announcements

Irhythm Technologies Earnings
Irhythm Technologies’s price-to-earnings ratio stands at None
Read More

About Irhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Organization	Irhythm Technologies
Employees	2000
CEO	Mr. Quentin S. Blackford
Industry	Health Technology

Management People of Irhythm Technologies

Name	Title
Mr. Quentin S. Blackford	President, CEO & Director
Dr. Minang P. Turakhia M.D., M.S.	Chief Medical & Scientific Officer and Executive VP of Product Innovation
Mr. Patrick Michael Murphy J.D.	Chief Business & Legal Officer
Mr. Chad M. Patterson	Chief Commercial Officer
Mr. Mervin Smith	Executive Vice President of Business Operations
Mr. Marc Rosenbaum	Senior VP of Finance & Chief Accounting Officer
Mr. Daniel G. Wilson	Executive VP of Corporate Development & Investor Relations
Ms. Sumi Shrishrimal	Executive VP & Chief Risk Officer
Ms. Stephanie Zhadkevich	Director of Investor Relations

Important FAQs about investing in IRTC Stock from India :

What is Irhythm Technologies share price today?

Irhythm Technologies share price today stands at $108.85, Open: $108.15 ; Previous Close: $107.74 ; High: $109.81 ; Low: $106.89 ; 52 Week High: $124.12 ; 52 Week Low: $55.92.

The stock opens at $108.15, after a previous close of $107.74. The stock reached a daily high of $109.81 and a low of $106.89, with a 52-week high of $124.12 and a 52-week low of $55.92.

Can Indians buy Irhythm Technologies shares?

Yes, Indians can invest in the Irhythm Technologies (IRTC) from India.

With INDmoney, you can buy Irhythm Technologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Irhythm Technologies at zero transaction cost.

How can I buy Irhythm Technologies shares from India?

It is very easy to buy Irhythm Technologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Irhythm Technologies (IRTC) be purchased?

Yes, you can buy fractional shares of Irhythm Technologies with INDmoney app.

What are the documents required to start investing in Irhythm Technologies stocks?

To start investing in Irhythm Technologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.